NEAT1 and ovarian carcinoma: Linc01118, UCA1, Nuclear-enriched abundant transcript 1 (NEAT1) contributed paclitaxel-resistance to ovarian cancer (Shi and Wang 2018; Wang et al. 2018a; An et al. 2017), FTH1P3, H19 activated paclitaxel-resistance in breast cancer (Wang et al. 2018b; Han et al. 2018), Linc00518, Linc00473, PVT1 promoted paclitaxel-resistance of prostate cancer, colorectal cancer and glioma respectively (He et al. 2019; Wang et al. 2018c; Song et al. 2018), and NEAT1, KCNQ1OT1, ANRIL conferred paclitaxel-resistance to lung cancer (Li et al. 2019; Ren et al. 2017; Xu et al. 2017).